Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies

Yusheng Zhang, Wenlu Hu, Tianqi Li, Zhou Pan, Jinlei Sun, Yujie He, Wenjuan Guan, Lijuan Zhang, Chaofeng Lian, Shengyun Liu, Panpan Zhang Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaCorrespondence: Pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang Y, Hu W, Li T, Pan Z, Sun J, He Y, Guan W, Zhang L, Lian C, Liu S, Zhang P
Format: Article
Language:English
Published: Dove Medical Press 2025-05-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/shared-and-distinctive-inflammation-related-protein-profiling-in-idiop-peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849728493748748288
author Zhang Y
Hu W
Li T
Pan Z
Sun J
He Y
Guan W
Zhang L
Lian C
Liu S
Zhang P
author_facet Zhang Y
Hu W
Li T
Pan Z
Sun J
He Y
Guan W
Zhang L
Lian C
Liu S
Zhang P
author_sort Zhang Y
collection DOAJ
description Yusheng Zhang, Wenlu Hu, Tianqi Li, Zhou Pan, Jinlei Sun, Yujie He, Wenjuan Guan, Lijuan Zhang, Chaofeng Lian, Shengyun Liu, Panpan Zhang Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaCorrespondence: Panpan Zhang, Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China, Email panpanzhang2016@163.com Shengyun Liu, Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China, Email fccliusy2@zzu.edu.cnPurpose: Due to the heterogeneous nature of the diseases, treatment efficacy and prognosis vary for idiopathic inflammatory myopathy (IIM) patients with different myositis specific autoantibodies (MSAs). This study aimed to investigate the inflammation-related protein profiling of IIM patients with different MSAs. In addition, the shared and distinctive inflammation-related protein profiling in IIM with/without anti-MDA5 autoantibodies.Methods: Seventy-seven patients with IIM of different MSAs and 53 gender/age matched healthy controls (HCs) were enrolled in this study. Ninety-two inflammation-related proteins were detected by Olink proteomics. We identified differentially expressed proteins (DEPs), and performed gene set enrichment analysis and KEGG pathway analysis. In addition, correlation between DEPs and serological parameters were performed. The least absolute shrinkage and selection operator (Lasso) regression algorithm of machine learning was used to screen biomarkers related to anti-MDA5+ DM.Results: Compared with HCs, 36 inflammation-related proteins were identified as DEPs. The top 10 DEPs were CXCL10, CXCL11, CXCL9, CXCL8, S100A12, IL-6, CCL2, CCL8, IL-10 and CCL3. The inflammation-related proteins and cytokine-cytokine receptor interaction pathway were more strikingly expressed in patients with anti-MDA5+ DM patients than in anti-MDA5- IIM patients. In addition, multiple DEPs correlated with serum ferritin, KL-6, muscle enzymes. For the first time, we established that a multi-factor panel comprising CX3CL1, IL-17C, IL-18R1, CCL20, and TNF (AUC = 0.824) serves as a highly efficient diagnostic biomarker for anti-MDA5+ DM.Conclusion: Plasma profiling revealed that inflammation and inflammatory pathways were extremely elevated in patients with IIM, especially in patients with anti-MDA5 autoantibodies. The shared and distinctive inflammation-related protein signature was demonstrated in patients with/without anti-MDA5 autoantibodies. The expression of CX3CL1 was significantly higher in anti-MDA5+ DM than in patients without anti-MDA5 autoantibodies. In addition, CX3CL1 correlated with ESR, serum ferritin, CK enzymes and disease activity, indicating that CX3CL1 participated in inflammation status of anti-MDA5+ DM.Keywords: idiopathic inflammatory myopathy, anti-MDA5+ dermatomyositis, myositis specific autoantibodies, inflammation-related biomarkers, CX3CL1
format Article
id doaj-art-9da9bd99f3f54474afdc520569de613f
institution DOAJ
issn 1178-7031
language English
publishDate 2025-05-01
publisher Dove Medical Press
record_format Article
series Journal of Inflammation Research
spelling doaj-art-9da9bd99f3f54474afdc520569de613f2025-08-20T03:09:32ZengDove Medical PressJournal of Inflammation Research1178-70312025-05-01Volume 18Issue 160096024102749Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 AutoantibodiesZhang Y0Hu W1Li T2Pan Z3Sun J4He Y5Guan W6Zhang L7Lian C8Liu S9Zhang P10Department of Rheumatology and Clinical ImmunologyDepartment of Rheumatology and Clinical ImmunologyDepartment of Rheumatology and Clinical ImmunologyDepartment of Rheumatology and Clinical ImmunologyDepartment of Rheumatology and Clinical ImmunologyDepartment of Rheumatology and Clinical ImmunologyDepartment of Rheumatology and Clinical ImmunologyDepartment of Rheumatology and Clinical ImmunologyDepartment of Rheumatology and Clinical ImmunologyDepartment of Rheumatology and Clinical ImmunologyRheumatology and Clinical ImmunologyYusheng Zhang, Wenlu Hu, Tianqi Li, Zhou Pan, Jinlei Sun, Yujie He, Wenjuan Guan, Lijuan Zhang, Chaofeng Lian, Shengyun Liu, Panpan Zhang Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of ChinaCorrespondence: Panpan Zhang, Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China, Email panpanzhang2016@163.com Shengyun Liu, Department of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People’s Republic of China, Email fccliusy2@zzu.edu.cnPurpose: Due to the heterogeneous nature of the diseases, treatment efficacy and prognosis vary for idiopathic inflammatory myopathy (IIM) patients with different myositis specific autoantibodies (MSAs). This study aimed to investigate the inflammation-related protein profiling of IIM patients with different MSAs. In addition, the shared and distinctive inflammation-related protein profiling in IIM with/without anti-MDA5 autoantibodies.Methods: Seventy-seven patients with IIM of different MSAs and 53 gender/age matched healthy controls (HCs) were enrolled in this study. Ninety-two inflammation-related proteins were detected by Olink proteomics. We identified differentially expressed proteins (DEPs), and performed gene set enrichment analysis and KEGG pathway analysis. In addition, correlation between DEPs and serological parameters were performed. The least absolute shrinkage and selection operator (Lasso) regression algorithm of machine learning was used to screen biomarkers related to anti-MDA5+ DM.Results: Compared with HCs, 36 inflammation-related proteins were identified as DEPs. The top 10 DEPs were CXCL10, CXCL11, CXCL9, CXCL8, S100A12, IL-6, CCL2, CCL8, IL-10 and CCL3. The inflammation-related proteins and cytokine-cytokine receptor interaction pathway were more strikingly expressed in patients with anti-MDA5+ DM patients than in anti-MDA5- IIM patients. In addition, multiple DEPs correlated with serum ferritin, KL-6, muscle enzymes. For the first time, we established that a multi-factor panel comprising CX3CL1, IL-17C, IL-18R1, CCL20, and TNF (AUC = 0.824) serves as a highly efficient diagnostic biomarker for anti-MDA5+ DM.Conclusion: Plasma profiling revealed that inflammation and inflammatory pathways were extremely elevated in patients with IIM, especially in patients with anti-MDA5 autoantibodies. The shared and distinctive inflammation-related protein signature was demonstrated in patients with/without anti-MDA5 autoantibodies. The expression of CX3CL1 was significantly higher in anti-MDA5+ DM than in patients without anti-MDA5 autoantibodies. In addition, CX3CL1 correlated with ESR, serum ferritin, CK enzymes and disease activity, indicating that CX3CL1 participated in inflammation status of anti-MDA5+ DM.Keywords: idiopathic inflammatory myopathy, anti-MDA5+ dermatomyositis, myositis specific autoantibodies, inflammation-related biomarkers, CX3CL1https://www.dovepress.com/shared-and-distinctive-inflammation-related-protein-profiling-in-idiop-peer-reviewed-fulltext-article-JIRidiopathic inflammatory myopathyanti-MDA5+ dermatomyositismyositis specific autoantibodiesinflammation-related biomarkersCX3CL1
spellingShingle Zhang Y
Hu W
Li T
Pan Z
Sun J
He Y
Guan W
Zhang L
Lian C
Liu S
Zhang P
Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies
Journal of Inflammation Research
idiopathic inflammatory myopathy
anti-MDA5+ dermatomyositis
myositis specific autoantibodies
inflammation-related biomarkers
CX3CL1
title Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies
title_full Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies
title_fullStr Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies
title_full_unstemmed Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies
title_short Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies
title_sort shared and distinctive inflammation related protein profiling in idiopathic inflammatory myopathy with without anti mda5 autoantibodies
topic idiopathic inflammatory myopathy
anti-MDA5+ dermatomyositis
myositis specific autoantibodies
inflammation-related biomarkers
CX3CL1
url https://www.dovepress.com/shared-and-distinctive-inflammation-related-protein-profiling-in-idiop-peer-reviewed-fulltext-article-JIR
work_keys_str_mv AT zhangy sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies
AT huw sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies
AT lit sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies
AT panz sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies
AT sunj sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies
AT hey sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies
AT guanw sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies
AT zhangl sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies
AT lianc sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies
AT lius sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies
AT zhangp sharedanddistinctiveinflammationrelatedproteinprofilinginidiopathicinflammatorymyopathywithwithoutantimda5autoantibodies